Finally, numerous studies have described the expression of NRP1 on tumour cells, which can modify EC behaviour and alter their angiogenic potential [14, 36, 45, 46], with an impact on tumour cell proliferation in human pancreatic and renal cell cancer [36, 47, 48]. The gene discussed is NRP1; the disease is renal cell adenocarcinoma.